Lawnicka et al [40] analyzed the serum concentrations of IGF-1R in patients with thyroid cancer, including ATC, and found significantly elevated concentrations in the blood samples of patients with ATC compared to the healthy control group. This evidence concerns the gene IGF1R and thyroid cancer.